Using e-Technologies to Maximize Physical Activity After Cancer Treatment

NCT07535918 — Not applicable, Not yet recruiting, 750 participants, University of Florida

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Using e-Technologies to Maximize Physical Activity After Cancer Treatment: The eMPACT Trial

RegistryNCT07535918
StatusNot yet recruiting
PhaseNot applicable
Study typeInterventional; randomized, parallel, masking: none, prevention
Enrollment750 (Estimated)
SponsorUniversity of Florida (Other)
ConditionsCancer
InterventionsCancer Exercise App (Behavioral)
Datesstart 2026-10-01 (estimated), primary completion 2028-05-01 (estimated), completion 2028-05-01 (estimated), first posted 2026-04-17, last updated 2026-08-27

Related Papers Related Patents Related Grants Related Experts
All trials for Cancer All trials of Cancer Exercise App

-Summary

The Cancer Exercise app (CEA) is designed to promote physical activity among cancer survivors. The proposed randomized controlled clinical trial will investigate, in adults who have completed cancer treatment, the effects of a 12-week home-based exercise program, delivered using CEA, on physical activity levels. Participants will be randomized into one of two groups: (1) CEA or (2) Usual Care.

Expand all sections  ·  Collapse all

+Arms and interventions

ArmTypeInterventionsDescription
Cancer Exercise app groupExperimentalBehavioral: Cancer Exercise App
Usual Care groupNo interventionParticipants assigned to Usual Care group will receive no intervention. After completing the post-intervention assessments, they will be provided with information on how to download and use the Cancer exercise app.
  • Cancer Exercise App (Behavioral): Use of Cancer Exercise app to increase physical activity levels among cancer survivors.

+Outcome measures

Primary outcomes

  • Change in moderate to vigorous physical activity from pre- to post-intervention [Baseline and following the 12-week intervention]: Moderate to vigorous physical activity will be assessed using the International Physical Activity Questionnaire, a well-validated and reproducible questionnaire for use among cancer survivors

+Eligibility

Sex: All, ages: 18 Years to 85 Years

Inclusion Criteria:

* 18 to 85 years of age
* Diagnosed with stage I-III cancer
* Completed all primary cancer treatments (e.g., surgery, radiation, chemotherapy) at least 6 months prior to enrollment. Adjuvant endocrine therapy, CDK4/6 inhibitors, PARP inhibitors, immunotherapy, and bisphosphonates are allowed within 6 months of study enrolment and during study participation.
* Own a smartphone with data plan or access to WiFi (Apple or Android)
* Medical clearance provided or no medical clearance needed based on exercise preparticipation screening.

Exclusion Criteria:

* consistently engage in >300 min/week of moderate-intensity physical activity or 150 min/week of vigorous-intensity physical activity in the past 3 months
* receiving or scheduled to receive surgery or radiation during study participation
* have stage IV metastatic cancer or evidence of cancer recurrence
* have multiple myeloma
* have received bone marrow or hematopoietic stem cell transplant within past year
* are unable to walk without support or have severe weakness or balance problems that limit safe participation in exercise
* contraindications to participate in unsupervised exercise
* are pregnant
* unable to read, speak and understand English

+Investigators